Related Experiment Video

Updated: Jun 16, 2026

Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells
07:22

Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells

Published on: March 28, 2013

Clking on PGC-1alpha to inhibit gluconeogenesis

Carles Cantó1, Johan Auwerx

  • 1Ecole Polytechnique Fédérale de Lausanne, Switzerland.

Cell Metabolism
|January 21, 2010
PubMed

Insights

The Clk2 kinase, an Akt substrate, directly inhibits PGC-1alpha, reducing hepatic glucose production. This finding clarifies the link between Akt activation and gluconeogenic repression in metabolic regulation.

Area of Science:

  • Biochemistry
  • Metabolic Regulation
  • Molecular Biology

Background:

  • The relationship between Akt activation and the repression of gluconeogenesis is not fully understood.
  • Akt signaling plays a crucial role in glucose metabolism, but its precise mechanisms in regulating hepatic glucose production require further elucidation.

Purpose of the Study:

  • To investigate the molecular mechanisms linking Akt activation to the suppression of hepatic glucose production.
  • To identify novel Akt substrates involved in the regulation of gluconeogenesis.

Main Methods:

  • The study employed biochemical assays to examine the interaction between Akt, Clk2 kinase, and PGC-1alpha.
  • Phosphorylation assays were performed to determine the effect of Clk2 on PGC-1alpha activity.
  • In vitro and in vivo models were used to assess the impact on hepatic glucose production.

Main Results:

  • Rodgers and colleagues identified Clk2 kinase as a direct substrate of Akt.
  • Clk2 kinase was found to directly phosphorylate and inhibit PGC-1alpha, a key regulator of gluconeogenesis.
  • Inhibition of PGC-1alpha by Clk2 led to a blunting of hepatic glucose production.

Conclusions:

  • Clk2 kinase acts as a crucial mediator in the Akt-dependent repression of gluconeogenesis.
  • The phosphorylation of PGC-1alpha by Clk2 represents a key molecular event in controlling hepatic glucose output.
  • This discovery provides a new understanding of metabolic regulation and potential therapeutic targets for glucose metabolism disorders.

More Related Videos

Human Pseudoislet System for Synchronous Assessment of Fluorescent Biosensor Dynamics and Hormone Secretory Profiles08:04

Human Pseudoislet System for Synchronous Assessment of Fluorescent Biosensor Dynamics and Hormone Secretory Profiles

Published on: November 3, 2023

Related Concept Videos

GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...